| |
 |
 |
PUBLICATIONS
1.Tai-Jan Chiu, Yi-Ju Chen, Cheng-Hua Huang. Massive anterior chest wall metastasis of ovarian cancer and prolonged survival after treatment: a case report. J Reprod Med. 2008 May;53(5):373-7. (non-SCI)
2.Tai-Jan Chiu; Jun-Wen Wang; Yi-Ju Chen; Yeh Tang; Cheng-Hua Huang. Intraarterial Cisplatin and intravenous adriamyc in in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan. Chang Gung Med J. 2009 Jan-Feb;32(1):72-80. (non-SCI)
3.Chien-Ting Liu, Tai-Jan Chiu, Tai-Lin Huang, Chih-Yen Chien, Fu-Min Fang. Impact of Comorbidity on Survival for Locally Advanced Head and Neck Cancer Patients Treated by Radiotherapy or Radiotherapy plus Chemotherapy. Chang Gung Med J. 2010 May-June;33(3):283-291. (non-SCI)
4.Yu-Li Su, Chien- Ting Liu, Tai-Jan Chiu , Shan- Hsuan Li, Tai-Lin Huang, Yen- Yang Chen, Yen Tang, Kun- Ming Rau, Cheng- Hua Huang Metastatic Mucinous Colorectal Cancer: An Important
Subtype of Colorectal Cancer with Poor Response to Chemotherapy and Overall Survival. J. Cancer Res. Pract. 26( 6), 221 - 230, 2010 (non-SCI)
5.Chiu, Tai-Jan, Chen CH, Chien CY, Li SH, Tsai HT, Chen YJ. High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome
in unresectable squamous cell carcinoma of head and neck in a betel-chewing area.J Transl Med. 2011 Mar 23;9:31 (SCI;IF=7.4; MEDICINE, RESEARCH & EXPERIMENTAL 29/136)
6.Chen YJ, Rau KM, Chien CY, Fang FM, Huang TL, Chiu, Tai-Jan. High p16 expression predicts a positive response to chemoradiotherapy in stage IVa/b head and neck squamous cell carcinoma. Asian Pac J Cancer Prev.
2011;12(3):649-55 (non-SCI)
7.Wu Chia-Che, Tai-jan chiu, Meng-Chih Lin, Jui-Ling Wang, Kun-Ming Rau, Chen YY , Huang CH*.Pemetrexed as third-line chemotherapy for locally advanced and metastatic non-small cell lung cancer (NSCLC) : A retrospective analysis.2011;27:157-164. (non-SCI)
8.Rau KM, Huang CC, Chiu TJ, Chen YY, Lu CC, Liu CT, Pei SN, Wei YC. Neovascularization evaluated by CD105 correlates well with prognostic factors in breast cancers. Exp Ther Med. 2012 Aug;4(2):231-236. (SCI;IF=2.7; MEDICINE, RESEARCH & EXPERIMENTAL 92/136)
9.Chiu TJ, Chen YJ, Rau KM, Chen CH, Chien CY, Li SH, Tsai HT, Eng HL. Midkine neurite growth-promoting factor 2 expression as a potential prognostic marker of adjuvant therapy in head and neck squamous cell carcinoma. Biomarkers. 2013 Oct 28. (SCI;IF=2.6; BIOTECHNOLOGY & APPLIED MICROBIOLOGY 108/158)
10.Hwang CF, Shiu LY, Su LJ, Yu-Fang Yin, Wang WS, Huang SC, Chiu TJ, Huang CC, Zhen YY, Tsai HT, Fang FM, Huang TL, Chen CH. Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis. PLoS One. 2013 Dec 27;8(12):e84218 (SCI;IF=3.7; MULTIDISCIPLINARY SCIENCES 26/73)
11.Ming-Chun Ma, Yen-Yang Chen, Shau-Hsuan Li, Yu F. Cheng, Chih-Chi Wang, Tai-Jan Chiu, Sung-Nan Pei, Chien-Ting Liu, Tai-Lin Huang, Chen- Hua Huang, Yu-Li Su, Yen-Hao Chen, Sheng-Nan Lu and Kun-Min Rau. Intraarterial Chemotherapy with Doxorubicin and Cisplatin is Effective for Advanced Hepatocellular Cell Carcinoma. The Scientific World Journal Volume 2014 (2014), Article ID 160138, 8 page (non-SCI) Chen CH, Chang AY, Li SH, Tsai HT, Shiu LY, Su LJ, Wang WL, Chiu TJ, Luo SD, Huang TL, Chien CY. Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer. Mol Cancer. 2015 Apr 12;14:83. (SCI;IF=5.43; BIOCHEMISTRY & MOLECULAR BIOLOGY 4/285)
12.Sheng-Dean Luo, Yi-Ju Chen, Chien-Ting Liu, Kun-Ming Rau, Yi-Ching Chen, Hsin-Ting Tsai, Chang-Han Chen, Tai-Jan Chiu*; Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma, BioMed Research international 2015; 2015: 508587. (SCI;IF=3.246; BIOTECHNOLOGY & APPLIED MICROBIOLOGY 90/159)
13.Yang MC, Wang HC, Hou YC, Tung HL, Chiu TJ, Shan YS. Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine. Mol Cancer. 2015 Oct 12;14(1):179. (SCI;IF=5.43; BIOCHEMISTRY & MOLECULAR BIOLOGY 4/285)
14.Li SH, Lin WC, Huang TL, Chen CH, Chiu TJ, Fang FM, Huang WT, Hsu CM, Luo SD, Lai CC, Su YY, Chuang HC, Chien CY. Significance of mammalian target of rapamycin in patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil. Head Neck. Head Neck. 2016 Apr;38 Suppl 1:E844-52. (SCI;IF=2.9;Otorhinolaryngology 8/43)
15.Su YY, Chien CY, Luo SD, Huang TL, Lin WC, Fang FM, Chiu TJ, Chen YH, Lai CC, Hsu CM, Li SH. Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil. World J Surg Oncol. 2016 Mar 22;14:86. (SCI;IF=3.2; Surgery 47/213)
16.Fang FM, Chuang HC, Chou SY, Huang TL, Wang CJ, Lin YT, Chiu TJ, Lin WC, Li SH, Su YY, Chien CY. The Therapeutic Benefit of Radical Resection for T4b Oral Cavity Squamous Cell Carcinoma with Partial or Complete Response After Radical Chemo-Intensity-Modulated Radiotherapy (IMRT). Ann Surg Oncol. 2016 Dec;23(Suppl 5):866-873. (SCI;IF=3.7; Surgery 26/213)
17.Chen CH, Tsai HT, Chuang HC, Shiu LY, Su LJ, Chiu TJ, Luo SD, Fang FM, Huang CC, Chien CY. Metformin disrupts malignant behavior of oral squamous cell carcinoma via a novel signaling involving Late SV40 factor/Aurora-A. Sci Rep. 2017 May 2;7(1):1358. (SCI;IF=4.6; Multidisciplinary sciences 21/73)
18.Tai-Jan Chiu*, Sheng-Dean Luo, Chih-Yen Chien, Yan-Ye Su, Tai-Lin Huang, Wei-Che Lin, Fu-Min Fang, Chang-Han Chen, Shun-Yu Su, Shau- Hsuan Li*. Treatment Outcome of Patients with Unresectable Stage IVB Head and Neck Squamous Cell Carcinoma Receiving Induction Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil. International Journal of Head and Neck Science 1(2): 121-130, 2017 (non-SCI)
19.Rau KM, Su YL, Li SH, Hsieh MC, Wu SC, Chou FF, Chiu TJ, Chen YH, Liu CT. High expression of endoglin in primary breast cancer may predict response to neoadjuvant chemotherapy. Mol Med Rep. 2017 Nov;16(5):7185- 7190. doi: 10.3892/mmr.2017.7555. (SCI;IF=3.2; Surgery 47/213)
20.Ma MC*, Chen YJ*, Chiu TJ, Lan J, Liu CT, Chen YC, Tien HH, Chen YY. Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma. BMC Cancer. 2018 Feb 27;18(1):227. (SCI;IF=3.8; Oncology 109/242)
21.Tai-Jan Chiu*. Combinatorial Methods of Immunotherapy Open New Opportunities in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Review article. International Journal of Head and Neck Science 2(1): 5-13, 2018. (non-SCI)
22.Ma MC*, Chiu TJ, Lu HI, Huang WT, Lo CM, Tien WY, Lan YC, Chen YY, Chen CH, Li SH. SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma. J Cardiothorac Surg. 2018 Apr 10;13(1):25. (SCI;IF=1.6; CARDIAC & CARDIOVASCULAR SYSTEMS 119/143)
23.Ma MC, Chiu TJ, Lu HI, Huang WT, Lo CM, Tien WY, Lan YC, Chen YY, Chen CH, Li SH. Oncogenic Fibulin-5 SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma. J Cardiothorac Surg. 2018 Apr 10;13(1):25. (SCI;IF=1.6; Surgery 146/213)
24.Chiu TJ*, Lu HI, Chen CH, Huang WT, Wang YM, Lin WC, Li SH. Osteopontin Expression Is Associated with the Poor Prognosis in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy. Biomed Res Int. 2018 Apr 30;2018:9098215. doi: 10.1155/2018/9098215. (SCI;IF=3.246; Biotechnology &applied microbiology 89/162)
25.Lee PC, Fang YF, Yamaguchi H, Wang WJ, Chen TC, Hong X, Ke B, Xia W, Wei Y, Zha Z, Wang Y, Kuo HP, Wang CW, Tu CY, Chen CH, Huang WC, Chiang SF, Nie L, Hou J, Chen CT, Huo L, Yang WH, Deng R, Nakai K, Hsu YH, Chang SS, Chiu TJ, Tang J, Zhang R, Wang L, Fang B, Chen T, Wong KK, Hsu JL, Hung MC. Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer. Cancer Cell. 2018 Dec 10;34(6):954-969.e4. doi: 10.1016/j.ccell.2018.11.007. (SCI;IF=50.3; Cell Biology 4/191)
26.Wang HC, Lin YL, Hsu CC, Chao YJ, Hou YC, Chiu TJ, Huang PH, Tang MJ, Chen LT, Shan YS. Pancreatic stellate cells activated by mutant KRAS- mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8. Theranostics. 2019 Sep 23;9(24):7168-7183. doi: 10.7150/thno.36830. eCollection 2019. (SCI;IF=12.4; MEDICINE, RESEARCH & EXPERIMENTAL 8/136)
27.Luo SD, Chen WC, Wu CN, Yang YH, Li SH, Fang FM, Huang TL, Wang YM, Chiu TJ*, Wu SC. Low-Dose Aspirin Use Significantly Improves the Survival of Late-stage NPC: A Propensity Score-Matched Cohort Study in Taiwan. Cancers (Basel). 2020 Jun 12;12(6):E1551. doi: 10.3390/cancers12061551. (SCI;IF=5.2; Oncology 71/242)
28.Chiu TJ*, Hsieh MJ, Lin YC, Weng CC, Weng YT, Hsiao CC, Cheng KH. Inactivation of APC Induces CD34 Upregulation to Promote Epithelial- Mesenchymal Transition and Cancer Stem Cell Traits in Pancreatic Cancer. Int J Mol Sci. 2020 Jun 23;21(12): E4473. doi: 10.3390/ijms21124473. (SCI;IF=5.6; Biochemistry & molecular biology 65/285)
29.Tsai MH, Chuang HC, Lin YT, Lu H, Fang FM, Huang TL, Chiu TJ, Li SH, Chien CY. Predictors of hospital expenses and hospital stay among patients undergoing total laryngectomy: Cost effectiveness analysis. PLoS One. 2020 Jul 16;15(7):e0236122. doi: 10.1371/journal.pone.0236122. eCollection 2020. (SCI;IF=3.7; MULTIDISCIPLINARY SCIENCES 26/73)
30.Chuang HC, Tsai MH, Lin YT, Chou MH, Huang TL, Chiu TJ, Lu H, Fang FM, Chien CY. The Clinical Impacts of Pretreatment Peripheral Blood Ratio on Lymphocytes, Monocytes, and Neutrophils Among Patients with Laryngeal/Hypopharyngeal Cancer Treated by Chemoradiation/Radiation. Cancer Manag Res. 2020 Sep 25;12:9013-9021. doi: 10.2147/CMAR.S275635. (SCI;IF=3.3; Oncology 135/242)
31.Tai-Jan Chiu*, Yi-Ju Chen, Fang‐Ying Kuo, Yen-Yang Chen. Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular–cholangiocarcinoma PLoS One. 2020 Dec 11;15(12):e0240791. doi: 10.1371/journal.pone.0240791. eCollection 2020. (SCI;IF=3.7; MULTIDISCIPLINARY SCIENCES 26/73)
32.Kuo MC, Su PJ, Huang CC, Luo HL, Chiu TJ, Li SH, Wu CC, Liu TT, Cheng YT, Kang CH, Su YL. Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World Practice. Front Oncol. 2020 Nov 27;10:584834. doi: 10.3389/fonc.2020.584834. eCollection 2020(SCI;IF=4.7; Oncology 85/242)
33.Luo SD, Wu SC, Chen WC, Wu CN, Chiu TJ, Yang YH, Li SH, Fang FM, Huang TL, Hsiao CC, Chen CH. Low-dose aspirin confers a survival benefit in patients with pathological advanced-stage oral squamous cell carcinoma. Sci Rep. 2021 Aug 25;11(1):17161. doi: 10.1038/s41598-021-96614-y (SCI;IF=4.6; Multidisciplinary sciences 21/73)
34.Luo SD, Chiu TJ, Chen WC, Wang CS. Sex Differences in Otolaryngology: Focus on the Emerging Role of Estrogens in Inflammatory and Pro-Resolvin Responses. Int J Mol Sci. 2021 Aug 16;22(16):8768. doi: 10.3390/ijms22168768. (SCI;IF=5.6; Biochemistry & molecular biology 65/285)
35.Chen WS, Luo SD, Chiu TJ, Wang YM, Chen WC, Chien CY, Fang FM, Huang TL, Li SH. Ribophorin II Overexpression Is Associated with Poor Response to Induction Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil in P16-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma. J Clin Med. 2021 Sep 12;10(18):4118 (SCI;IF=3.9; Medicine, General&internal 58/170)
36.Yu-Li Su *, Kai-Lung Tsai, Tai-Jan Chiu, Yueh-Ming Lin, Ko-Chao Lee, Chien-Chang Lu, Hong-Hwa Chen, Chia-Che Wu, Hung-Chih Hsu* Development and Validation of a Novel Serum Predictive Marker for Patients with Metastatic Colorectal Cancer on Regorafenib Treatment. Cancers 2021, 13, 5080. (SCI;IF=5.2; Oncology 71/242)
37.Tai-Jan Chiu, Yi-Ju Chen, Jui Lan, Yen-Yang Chen, Yueh-Chiu Chen, Shiao-Wu Lin, Hsin-Ting Tsai, Yu-Sheng Lin, Chang-Chun Hsiao*, Chang-
Han Chen* Downregulation of Notch3 links TIMP3 inhibition to suppress aggressive phenotypes of pancreatic ductal adenocarcinoma, American Journal
of Cancer Research (SCI;IF=5.3; Oncology 70/242)
38.Tai-Jan Chiu, Yung-Yeh Su, Shih-Hung Yang, Chung-Pin Li, Li-Yuan Bai6, Nai-Jung Chiang,Shih-Chang Chuang, Yan-Shen Shan, De-Chuan Chan, Li- Tzong Chen, Chia-Jui Yen, Cheng-Ming Peng, Yen-Yang Chen, Jen-Shi Chen, Wen-Chi Chou*. Nanoliposomal Irinotecan Pre-Emptive Dose Reduction in Patients with Pancreatic Ductal Adenocarcinoma: 667 Patients’ Experience within a Population-Based Study. Therapeutic Advances in Medical Oncology . 2021 Nov 20;13:17588359211058255. doi: 10.1177/17588359211058255. (SCI;IF=4.9; Oncology 78/242)
39.Wu CN, Wu SC, Chen WC, Yang YH, Chin JC, Chien CY, Fang FM, Li SH, Luo SD, Chiu TJ*. Angiotensin II receptor blockers and oral squamous cell carcinoma survival: A propensity-score-matched cohort study. PLoS One 2021 Dec 2;16(12):e0260772. (SCI;IF=3.7; MULTIDISCIPLINARY SCIENCES 26/73)
40.Chiu TJ, Su YY, Yang SH, Li CP, Bai LY, Chiang NJ, Chuang SC, Shan YS, Chan DC, Chen LT, Yen CJ, Peng CM, Chen YY, Chen JS, Chou WC. Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients`experience within a population-based study. Ther Adv Med Oncol. 2021 Nov 20;13:17588359211058255. doi: 10.1177/17588359211058255. eCollection 2021 (SCI;IF=4.9; Oncology 78/242) (主論文3)
41.Lee CL, Chen WS, Wee Y, Wang CS, Chen WC, Chiu TJ, Wang YM, Wu CN, Yang YH, Luo SD, Wu SC. Direct Oral Anticoagulants Are Associated with Superior Survival Outcomes than Warfarin in Patients with Head and Neck Cancers. Cancers (Basel). 2022 Jan 29;14(3):703. doi: 10.3390/cancers14030703 (SCI;IF=5.2; Oncology 71/242)
42.Chiu TJ, Yang SH, Chiu SC, Hsueh SW, Chiang NJ, Li CP, Bai LY, Cheng FM, Chuang SC, Shan YS, Chan DC, Chen LT, Yen CJ, Peng CM, Su YY, Chen YY, Chen JS, Chou WC. Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin. J Hepatobiliary Pancreat Sci. 2022 Jun;29(6):670-681. doi: 10.1002/jhbp.1128. Epub 2022 Mar 2. (SCI;IF=3; Surgery 58/212)
43.Yang SH, Chiang NJ, Chiu SC, Chou WC, Bai LY, Li CP, Su YY, Chiu TJ, Chuang SC, Peng CM, Chan DC, Chen JS, Yen CJ, Chen YY, Chiu CF, Chen LT, Shan YS. The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecan. Am J Cancer Res. 2022 Apr 15;12(4):1884-1898. eCollection 2022 (SCI;IF=5.3; Oncology 70/242)
44.Luo SD, Tsai HT, Chiu TJ, Li SH, Hsu YL, Su LJ, Tsai MH, Lee CY, Hsiao CC, Chen CH. Leptin Silencing Attenuates Lipid Accumulation through Sterol Regulatory Element-Binding Protein 1 Inhibition in Nasopharyngeal Carcinoma. Int J Mol Sci. 2022 May 20;23(10):5700. doi: 10.3390/ijms23105700. (SCI;IF=5.6; Biochemistry & molecular biology 65/285)
45.Luo SD, Tsai HT, Hwang CF, Chiu TJ, Li SH, Hsu YL, Hsiao CC, Chen CH. Aberrant miR-874-3p/leptin/EGFR/c-Myc signaling contributes to nasopharyngeal carcinoma pathogenesis. J Exp Clin Cancer Res. 2022 Jul 1;41(1):215. doi: 10.1186/s13046-022-02415-0. (SCI;IF=11.3; Oncology 25/242)
46.Su YY, Chiang NJ, Li CP, Yen CJ, Yang SH, Chou WC, Chen JS, Chiu TJ, Chen YY, Chuang SC, Bai LY, Chiu CF, Peng CM, Chan DC, Chiu SC, Yang YH, Shan YS, Chen LT. Dosing Pattern and Early Cumulative Dose of Liposomal Irinotecan in Metastatic Pancreatic Cancer: A Real-World Multicenter Study. Front Oncol. 2022 Jun 22;12:800842. doi: 10.3389/fonc.2022.800842. eCollection 2022 (SCI;IF=4.7; Oncology 85/242)
47.Chen YH, Luo SD, Wu SC, Wu CN, Chiu TJ, Wang YM, Yang YH, Chen WC. Clinical Characteristics and Predictive Outcomes of Recurrent Nasopharyngeal Carcinoma-A Lingering Pitfall of the Long Latency. Cancers (Basel). 2022 Aug 4;14(15):3795. doi: 10.3390/cancers14153795. (SCI;IF=5.2; Oncology 71/242)
48.Chao CY, Luo SD, Chen WC, Wu SC, Chiu TJ, Wang YM, Yang YH, Fang FM, Li SH, Li CY, Wu CN. Effect of glycated hemoglobin A1c on the survival of patients with oral squamous cell carcinoma: A multi-institutional database cohort study. Front Oncol. 2022 Aug 29;12:952616. doi: 10.3389/fonc.2022.952616. eCollection 2022 (SCI;IF=4.7; Oncology 85/242)
49.Chen YY, Hsueh SW, Yang SH, Chiu SC, Chiang NJ, Chiu TJ, Li CP, Bai LY, Chiu CF, Chuang SC, Shan YS, Chan DC, Chen LT, Yen CJ, Peng CM, Chen JS, Chou WC. Predictive value of albumin combined with neutrophil-to- lymphocyte ratio for efficacy and safety profiles in patients with pancreatic ductal adenocarcinoma receiving liposomal irinotecan plus 5-fluorouracil and leucovorin. Am J Cancer Res. 2022 Sep 15;12(9):4267-4278. eCollection 2022 (SCI;IF=5.3; Oncology 70/242)
50.Chiang NJ, Shan YS, Li CP, Yang SH, Su YY, Chiu SC, Bai LY, Chuang SC, Chan DC, Yen CJ, Peng CM, Chiu TJ, Chen YY, Chen JS, Chou WC. The impact of starting dose with or without subsequent dose escalation of liposomal irinotecan on treatment outcomes in patients with metastatic pancreatic ductal adenocarcinoma. Am J Cancer Res. 2022 Nov 15;12(11):5062-5073. eCollection 2022 (SCI;IF=5.3; Oncology 70/242)
51.Su YY, Chiang NJ, Yang YH, Yen CJ, Bai LY, Chiu CF, Chuang SC, Yang SH, Chou WC, Chen JS, Chiu TJ, Chen YY, Chan DC, Peng CM, Chiu SC, Li CP, Shan YS, Chen LT. Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer. Cancers (Basel). 2023 Feb 5;15(4):1008. doi: 10.3390/cancers15041008
52.Huang TL, Huang YM, Hou MM, Lu CH, Chao TY, Chiu TJ, Chang YS, Lin SH, Lin CH, Chen YH, Wang CH, Chen JS, Shen WC. Safety and effectiveness of transdermal buprenorphine in cancer pain: An observational study in Taiwan (SOOTHE). Asia Pac J Clin Oncol. 2023 Apr;19(2):e45-e53. doi: 10.1111/ajco.13772 (SCI;IF=1.9; Oncology 214/242)
53.Nie L, Wang YN, Hsu JM, Hou J, Chu YY, Chan LC, Huo L, Wei Y, Deng R, Tang J, Hsu YH, Ko HW, Lim SO, Huang K, Chen MK, Chiu TJ, Cheng CC, Fang YF, Li CW, Goverdhan A, Wu HJ, Lee CC, Wang WL, Hsu J, Chiao P, Wang SC, Hung MC. Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cells. Am J Cancer Res. 2023 Apr 15;13(4):1209-1239. eCollection 2023 (SCI;IF=5.3; Oncology 70/242)
54.Chen WC, Wu CN, Wang YM, Chiu TJ, Wu SC, Yang YH, Luo SD. Clinical Value of Endoscopic Esophageal Screening in Head and Neck Squamous Cell Carcinoma Patients. Otolaryngol Head Neck Surg. 2023 Sep 20. doi: 10.1002/ohn.51 (SCI;IF=3.4; Otorhinolaryngology 5/4311)
55.Chiu TJ, Chen CH, Chen YJ, Wee Y, Wang CS, Luo SD. Prognosis of Midkine and AT1R expression in resectable head and neck squamous cell carcinoma. Cancer Cell Int. 2023 Sep 24;23(1):212. doi: 10.1186/s12935-023- 03060-z (SCI;IF=5.8; Oncology 60/242)
56.Cha CH, Chen WC, Wang YM, Wu SC, Chiu TJ, Wu CN, Wee Y, Wang CS, Yang YH, Luo SD. Comparison of Fungal and Non-Fungal Rhinosinusitis by Culture-Based Analysis. J Pers Med. 2023 Sep 11;13(9):1368. doi: 10.3390/jpm13091368 (SCI;IF=3.4; Health care 41/106)
57.Tai-Jan Chiu. Notch3 expression affects aggressive phenotypes of pancreatic ductal adenocarcinoma.
|
|
